SUN-321 KIDNEY TRANSPLANT OUTCOMES FROM A RENAL TRANSPLANT PROGRAM IN UNITED ARAB EMIRATES. SINGLE CENTRE RETROSPECTIVE STUDY FROM 2008 TO 2015

Abstract

Expatriates constitute close to 90 % of the resident population of United Arab Emirates (UAE), most of whom are temporary residents. Due to these unique social circumstances, donors are not readily available for people in need for kidney transplant; many go abroad for commercial transplantation. Free at the point of delivery kidney transplant (KT) program was established in Sheikh Khalifa Medical City by the Government of UAE in 2008 to improve access to KT to all legal residents of the country. We present the short term and long term outcomes of all KT performed in this centre from 2008-15. All KT recipients from 2008 -15 were enrolled in this study and their demographics are shown in Table 1. In total 149 patients underwent KT from 26 various nationalities. All bar one were living (genetically related or unrelated) KT. Most patients received induction therapy( > 92%), Alemtuzamab was used in 99 and Basiliximab in 26 KT recipients. All KT recipients received triple immunosuppression plus CMV and PCP prophylaxis for 6 months. The 1 year allograft survival was 97% and 1 year patient survival was 99%. The median creatinine (in µmol/l) was 100 at 3 months, 97.5 at 1 year, and 86 at 5 year. (Table 2, Figure 1). The 1 year rejection rate was 12% and the 5 year graft survival was 94 %. There was only 1 case of urine leak, which was managed conservatively. We present the outcomes for the first 149 KT from this centre. The graft and patient outcomes are comparable to the more established KT centres. Our transplant program results shows it is possible to offer high quality KT in the region despite the unique socio economic challenges. This KT program has the capacity and the expertise to provide high volume KT to cater to exponential increase in demand this region is facing.